Abdo-Francis Juan Miguel, Sobrino-Cossío Sergio, Bernal-Sahagún Fernando, Hernández-Guerrero Angélica
Dirección General Adjunta Médica, Hospital General de México OD, Secretaría de Salud, México, D. F., Mexico.
Cir Cir. 2010 Jul-Aug;78(4):315-21.
Esophageal metaplasia progression is a consequence of chronic gastroesophageal reflux (CGR). Patients with this condition are frequently infected by Helicobacter pylori and show several symptoms including gastritis as well as ulcer formation. In addition, they present an increased risk for the development of gastric adenocarcinoma. Several pathogenic markers for Helicobacter pylori such as ureC, vacA and cagA genes have been described. Evidence indicates that direct injury to the epithelial mucosa is caused by cytotoxins and enzymes codified by these genes. We undertook this study to establish a relationship between the presence of pathogenic Helicobacter pylori strains and the presence of metaplasia progression in patients with CGR.
We detected the presence of Helicobacter pylori cagA and vacA positive strains in patients with CGR. Using polymerase chain reaction, we analyzed 120 samples obtained from 60 patients with CGR and 60 control group patients, including samples from both anatomic areas: cardia and gastric antrum.
We detected 56% of Helicobacter pylori positive patients; 57.5% of these patients were positive for either cagA(+) and/or vacA(+) Helicobacter pylori strains. Cardiac intestinal metaplasia was observed in 35% of the patients. A marked tendency was observed to develop cardiac intestinal metaplasia in those patients diagnosed with high-pathogenicity strains infected in both anatomic areas.
These results suggest that infection with Helicobacter pylori can be considered a risk factor for developing gastric cardiac intestinal metaplasia.
食管化生进展是慢性胃食管反流(CGR)的结果。患有这种疾病的患者经常感染幽门螺杆菌,并表现出多种症状,包括胃炎以及溃疡形成。此外,他们患胃腺癌的风险增加。已经描述了几种幽门螺杆菌的致病标志物,如ureC、vacA和cagA基因。有证据表明,这些基因编码的细胞毒素和酶会对上皮黏膜造成直接损伤。我们进行这项研究是为了确定致病性幽门螺杆菌菌株的存在与CGR患者化生进展之间的关系。
我们检测了CGR患者中幽门螺杆菌cagA和vacA阳性菌株的存在情况。使用聚合酶链反应,我们分析了从60例CGR患者和60例对照组患者中获得的120份样本,包括来自两个解剖部位(贲门和胃窦)的样本。
我们检测到56%的患者幽门螺杆菌呈阳性;其中57.5%的患者cagA(+)和/或vacA(+)幽门螺杆菌菌株呈阳性。35%的患者观察到贲门肠化生。在那些被诊断为在两个解剖部位均感染高致病性菌株的患者中,观察到明显的贲门肠化生发展趋势。
这些结果表明,幽门螺杆菌感染可被视为发生胃贲门肠化生的一个危险因素。